DR WYMAN CHAN INTERNATIONAL LIMITEDActive

Company number 07629417Private limited companyIncorporated 2011

Key figures

−£97,054-36.8%
Net assets 2024/25
-100 k-50 k050 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, DR WYMAN CHAN INTERNATIONAL LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k300 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand150,32710,2875,88242,43038,158
Total assets207,00968,70952,41387,186103,669
Total liabilities195,626107,849130,802158,116210,647
Net assets / total equity11,383-39,140-78,389-70,930-97,054
Average number of employees43344

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: DR WYMAN CHAN INTERNATIONAL LIMITED

Company

DR WYMAN CHAN INTERNATIONAL LIMITED is a private limited company registered with Companies House under company number 07629417. It was incorporated on 10 May 2011. Its status is active. The registered office is in London (W1D). Its nature of business (SIC 2007) is manufacture of medical and dental instruments and supplies (32500), wholesale of chemical products (46750).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files abridged accounts (unaudited). Net assets were −£97,054, down 36.8% on the previous year. Cash at bank and in hand was £38,158. Total assets were £103,669 and total liabilities £210,647. The company had an average of 4 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 24 May 2027.